Kymera Therapeutics is hiring for 8 jobs on Simplify. Start your career today.

Kymera Therapeutics

Kymera Therapeutics

Develops small molecule therapeutics to degrade disease-causing proteins

Biotechnology

Work Here? Claim Your Company

Company Overview
Kymera Therapeutics stands out as a pioneering biopharmaceutical company, utilizing its proprietary Pegasus platform to design small molecule protein degraders that target disease-causing proteins, a method that holds significant advantages over existing therapies. The company's focus on previously inadequately drugged biological pathways, particularly in immunology-inflammation and oncology, demonstrates its commitment to addressing unmet medical needs. With a culture driven by the invention of transformative medicines, Kymera is reshaping the approach to treating diseases where traditional modalities have fallen short.
Biotechnology

Company Stage

N/A

Total Funding

$879M

Founded

2016

Headquarters

Watertown, Massachusetts

Growth & Insights
Headcount

6 month growth

2%

1 year growth

14%

2 year growth

41%